Asia-Pacific Americas Africa Europe Middle East

BIOCON LTD

Company Profile:

BIOCON LTD. COMPANY PROFILE

Biocon Ltd. is an Indian biopharmaceutical company. It is primarily a manufacturer and developer, operating as a factory or production facility rather than solely a trading company.

Biocon Ltd. is a global biopharmaceutical enterprise focused on innovation and affordability to deliver high-quality, complex therapies. The company discovers, develops, manufactures, and markets novel biologics, biosimilars, and complex generic formulations. Its key therapeutic areas include diabetes, oncology, immunology, and other non-communicable diseases. Biocon has a strong presence in the biosimilars market and is known for its research and development capabilities, producing active pharmaceutical ingredients and finished dosage forms in its manufacturing facilities.

Enterprise Products

Here are some products manufactured or sold by Biocon Ltd, India:

* Recombinant Human Insulin (Insulin Glargine, Insulin Aspart)

* Biosimilars (e.g., Trastuzumab, Pegfilgrastim, Adalimumab)

* Immunosuppressants (e.g., Mycophenolate Mofetil, Tacrolimus)

* Small Molecules (e.g., Statins)

* Novel Biologics (e.g., Alzumab)

* Branded Formulations

* Generic Formulations

* APIs (Active Pharmaceutical Ingredients)

Business Registration Information:

Manager:

Siddharth Mittal (Chief Executive Officer & Managing Director), Kiran Mazumdar-Shaw (Executive Chairperson)

Phone:

+91 80 2808 2808

E-mail:

investor.relations@biocon.com

Official Website:
Address:

Biocon House, Tower 3, Semicon Park, Veerasandra Industrial Area, Phase II, Electronic City, Bengaluru 560 100, India.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.